Alexander Tereshchenko1, Michael McHugh1, Jessica K Lee1, Pedro Gonzalez-Alegre2, Kaitlin Crane3, Jeffrey Dawson3, Peg Nopoulos1,4,5. 1. Department of Psychiatry, University of Iowa Carver College of Medicine. 2. Department of Neurology, University of Pennsylvania. 3. Department of Biostatistics, University of Iowa College of Public Health. 4. Department of Neurology, University of Iowa Carver College of Medicine. 5. Department of Pediatrics, University of Iowa Carver College of Medicine.
Abstract
BACKGROUND AND OBJECTIVES: The hallmark clinical manifestation of Huntington's disease (HD), namely lower weight and BMI has been reported in prodromal HD (PreHD) adults and also in PreHD children. Here, we aim to evaluate anthropometric measures of growth and development (height, weight, body mass index (BMI)) in a group of children, adolescents, and young adults diagnosed with Juvenile Onset Huntington's Disease (JHD). METHODS: Growth measures for 18 JHD patients, documented prior to or shortly after diagnosis, were obtained through medical records. JHD growth measures were compared to a large sample (n = 274) of healthy children, as well as the Center for Disease Control (CDC) growth norms. RESULTS: After controlling for sex and age, the JHD subjects had no significant differences in height. However, they were an average of 10% lower than controls in weight and BMI. Using CDC norms, the JHD subjects had the same pattern of normal height but decrement in weight. Length of cytosine-adenine-guanine (CAG) repeat in the huntingtin gene was significantly correlated to measures of weight with longer CAG repeats being associated with more severe weight reduction. A subset of 4 subjects had measures that pre-dated onset of any symptom and were therefore prodromal JHD (preJHD). These subjects also had a significant decrement in BMI compared to CDC norms. CONCLUSIONS: Children with JHD have normal height, but significantly reduced weight and BMI, indicative of a specific deficit in body weight. As the preJHD subjects were also low in BMI, this suggests that these changes are directly due to the effect of the mutated gene on development, rather than symptom manifestation of the disease itself. Potential mechanisms of the weight decrement include energy deficiency due to mitochondrial dysfunction during development.
BACKGROUND AND OBJECTIVES: The hallmark clinical manifestation of Huntington's disease (HD), namely lower weight and BMI has been reported in prodromal HD (PreHD) adults and also in PreHD children. Here, we aim to evaluate anthropometric measures of growth and development (height, weight, body mass index (BMI)) in a group of children, adolescents, and young adults diagnosed with Juvenile Onset Huntington's Disease (JHD). METHODS: Growth measures for 18 JHD patients, documented prior to or shortly after diagnosis, were obtained through medical records. JHD growth measures were compared to a large sample (n = 274) of healthy children, as well as the Center for Disease Control (CDC) growth norms. RESULTS: After controlling for sex and age, the JHD subjects had no significant differences in height. However, they were an average of 10% lower than controls in weight and BMI. Using CDC norms, the JHD subjects had the same pattern of normal height but decrement in weight. Length of cytosine-adenine-guanine (CAG) repeat in the huntingtin gene was significantly correlated to measures of weight with longer CAG repeats being associated with more severe weight reduction. A subset of 4 subjects had measures that pre-dated onset of any symptom and were therefore prodromal JHD (preJHD). These subjects also had a significant decrement in BMI compared to CDC norms. CONCLUSIONS:Children with JHD have normal height, but significantly reduced weight and BMI, indicative of a specific deficit in body weight. As the preJHD subjects were also low in BMI, this suggests that these changes are directly due to the effect of the mutated gene on development, rather than symptom manifestation of the disease itself. Potential mechanisms of the weight decrement include energy deficiency due to mitochondrial dysfunction during development.
Entities:
Keywords:
Huntington’s disease; body weight; growth; juvenile
Authors: J Michael Andresen; Javier Gayán; Luc Djoussé; Simone Roberts; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; James F Gusella; Marcy E MacDonald; Richard H Myers; David E Housman; Nancy S Wexler Journal: Ann Hum Genet Date: 2006-12-19 Impact factor: 1.670
Authors: Amy L Bauernfeind; Sarah K Barks; Tetyana Duka; Lawrence I Grossman; Patrick R Hof; Chet C Sherwood Journal: Brain Struct Funct Date: 2013-11-02 Impact factor: 3.270
Authors: Carsten Saft; Jochen Zange; Jürgen Andrich; Klaus Müller; Katrin Lindenberg; Bernhard Landwehrmeyer; Matthias Vorgerd; Peter H Kraus; Horst Przuntek; Ludger Schöls Journal: Mov Disord Date: 2005-06 Impact factor: 10.338
Authors: N Ahmad Aziz; Hanno Pijl; Marijke Frölich; Marieke Snel; Trea C M Streefland; Ferdinand Roelfsema; Raymund A C Roos Journal: J Neurol Neurosurg Psychiatry Date: 2010-08-14 Impact factor: 10.154
Authors: Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer Journal: Proc Natl Acad Sci U S A Date: 2004-03-01 Impact factor: 11.205
Authors: Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero Journal: Neurobiol Dis Date: 2016-09-10 Impact factor: 5.996
Authors: Kalina Wiatr; Wojciech J Szlachcic; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel Journal: Mol Neurobiol Date: 2017-05-11 Impact factor: 5.590
Authors: Silvia Corrochano; Gonzalo Blanco; Debbie Williams; Jessica Wettstein; Michelle Simon; Saumya Kumar; Lee Moir; Thomas Agnew; Michelle Stewart; Allison Landman; Vassilios N Kotiadis; Michael R Duchen; Henning Wackerhage; David C Rubinsztein; Steve D M Brown; Abraham Acevedo-Arozena Journal: Hum Mol Genet Date: 2018-05-15 Impact factor: 6.150
Authors: Alexander V Tereshchenko; Jordan L Schultz; Ansley J Kunnath; Joel E Bruss; Eric A Epping; Vincent A Magnotta; Peg C Nopoulos Journal: Brain Sci Date: 2020-08-08